Staying Compliant: How To Maximize Global Regulatory Collaboration In The Marketing Of Combination Products

By Kevin Lentz and Ana Ladino

Combination products in the medical device industry now occupy a more substantial market segment and have altered the relationship between pharmaceutical manufacturers and drug delivery technology providers. These drug and delivery platforms must meet compliance standards, both individually and once they are combined, and throughout the development, testing, and marketing phases. This article focuses on the maximization of global regulatory collaboration in the marketing of combination products.